» Articles » PMID: 39691295

Antiapoptotic and Antinociceptive Effects of Aqueous Extract in Rats with Experimental Painful Diabetic Neuropathy

Overview
Journal Res Pharm Sci
Specialty Chemistry
Date 2024 Dec 18
PMID 39691295
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Neuropathy is one of the common complications of diabetes mellitus. This study aimed to determine the analgesic and antiapoptotic effects of the aqueous extract of L. (Ach) in rats with experimental painful diabetic neuropathy by behavioral and molecular procedures.

Experimental Approach: Thirty male Wistar rats were divided into 5 groups including control, diabetes + saline, and diabetes + Ach extract (doses of 150, 300, and 600 mg/kg/day for 3 weeks, orally). A tail-flick test was performed to assess the pain threshold in different groups. Western blotting test was used to evaluate the apoptotic (Bax, Bcl2, cleaved caspase-3, and cytochrome-c) and inflammatory (TNF-α and NF-kB) protein factors in the lumbar portion of the spinal cord tissue. Also, commercial assay kits were used to evaluate oxidative stress factors (MDA, GPx, and SOD enzyme activity) in the lumbar portion of the spinal cord tissue.

Findings/results: Results showed that administering Ach extract at the doses of 300 and 600 mg/kg/day significantly increased the nociception threshold in treated diabetic animals compared to untreated diabetic animals. Moreover, the treatment of diabetic animals with Ach extract (300 and 600 mg/kg/day) significantly reduced the oxidative stress, inflammation, and apoptosis biochemical indicators in the lumbar spinal cord tissue compared to the untreated diabetic group.

Conclusion And Implications: The findings showed that Ach extract has neuroprotective and anti-nociceptive effects in rats with diabetic neuropathy. The effects can be due to the inhibition of oxidative stress, inflammation, and apoptosis in the spinal cord tissue.

References
1.
Kandhare A, Raygude K, Ghosh P, Ghule A, Bodhankar S . Neuroprotective effect of naringin by modulation of endogenous biomarkers in streptozotocin induced painful diabetic neuropathy. Fitoterapia. 2012; 83(4):650-9. DOI: 10.1016/j.fitote.2012.01.010. View

2.
Pop-Busui R, Ang L, Holmes C, Gallagher K, Feldman E . Inflammation as a Therapeutic Target for Diabetic Neuropathies. Curr Diab Rep. 2016; 16(3):29. PMC: 5127166. DOI: 10.1007/s11892-016-0727-5. View

3.
Calcutt N . Diabetic neuropathy and neuropathic pain: a (con)fusion of pathogenic mechanisms?. Pain. 2020; 161(Suppl 1):S65-S86. PMC: 7521457. DOI: 10.1097/j.pain.0000000000001922. View

4.
Babizhayev M, Strokov I, Nosikov V, Savelyeva E, Sitnikov V, Yegorov Y . The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic.... Cell Biochem Biophys. 2014; 71(3):1425-43. DOI: 10.1007/s12013-014-0365-y. View

5.
Kaeidi A, Esmaeili-Mahani S, Abbasnejad M, Sheibani V, Rasoulian B, Hajializadeh Z . Satureja khuzestanica attenuates apoptosis in hyperglycemic PC12 cells and spinal cord of diabetic rats. J Nat Med. 2012; 67(1):61-9. DOI: 10.1007/s11418-012-0646-y. View